Skip to main content


Latest articles

01-03-2021 | Oncology | News | Article

Telemonitoring system may help identify COVID-19 in people with cancer

Digital health systems that allow patients to self-report toxicities related to cancer therapies can be successfully adapted to screen for COVID-19, Belgian researchers report.

26-02-2021 | Oncology | News | Article

Risk tool predicts chemotherapy toxicity in older breast cancer patients

US researchers have developed the Cancer and Aging Research Group–Breast Cancer score to help predict grade 3–5 chemotherapy-related toxicities in older patients with early-stage breast cancer.

25-02-2021 | Oncology | News | Article

CDKN2A alterations may predict ICI outcomes in metastatic urothelial cancer

Genomic alterations in CDKN2A are associated with worse clinical outcomes in patients with advanced urothelial carcinoma treated with immune checkpoint inhibitors, report US researchers.

24-02-2021 | Oncology | Highlight | Article

Survey reveals willingness of cancer patients to receive COVID-19 vaccine

A survey of patients attending four French cancer centers shows that over half are willing to be vaccinated against COVID-19.

23-02-2021 | Oncology | News | Article

Sharp reduction in new oncology trials during COVID-19 pandemic

Researchers report a marked decrease in the number of oncology clinical trials launched during the COVID-19 pandemic compared with the prepandemic period.

23-02-2021 | Oncology | News | Article

21-gene recurrence score underperforms in Black women with breast cancer

Black women with breast cancer are more likely than non-Hispanic White women to have a high-risk 21-gene Oncotype DX Breast Recurrence Score, and are more likely to die of breast cancer than their non-Hispanic White counterparts with a comparable score, US research shows.

Image Credits